Date Filed | Type | Description |
06/28/2023 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 960 shares
@ $0 |
|
05/19/2023 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Granted 4,199 restricted stock units
@ $0 |
|
01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2022 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 15,000 shares
@ $74.4252, valued at
$1.1M
Exercised 15,000 options to buy
@ $6.66, valued at
$99.9k
|
|
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/02/2021 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 775 shares
@ $0 |
|
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/07/2020 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Gifted 2,806 shares
@ $0 |
|
06/05/2020 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 890 shares
@ $0 |
|
05/28/2020 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Granted 30,000 options to buy
@ $3, valued at
$90k
|
|
05/21/2020 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Granted 6,018 options to buy
@ $119.93, valued at
$721.7k
|
|
05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/30/2020 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 17,687 shares
@ $99.3931, valued at
$1.8M
|
|
03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2019 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on Neon Therapeutics, Inc.
Txns:
| Granted 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
06/20/2019 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 1,155 shares
@ $0 |
|
05/23/2019 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Granted 10,000 options to buy
@ $79.79, valued at
$797.9k
|
|
05/15/2019 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Granted 30,000 options to buy
@ $3.29, valued at
$98.7k
|
|
11/05/2018 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Gifted 275 shares
@ $0 Gifted 200 shares
@ $0 Gifted 175 shares
@ $0 |
|
06/26/2018 |
3
| SHERWIN STEPHEN A (Director) has filed a Form 3 on Neon Therapeutics, Inc. |
06/14/2018 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 880 shares
@ $0 |
|
06/13/2018 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Sold 10,000 shares
@ $98.442, valued at
$984.4k
|
|
06/08/2018 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Granted 20,000 options to buy
@ $6.6, valued at
$132k
|
|
05/25/2018 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Granted 12,500 options to buy
@ $94.64, valued at
$1.2M
|
|
04/30/2018 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns:
| Paid exercise price by delivering 1,331 shares
@ $79.44, valued at
$105.7k
Exercised 15,000 options to buy
@ $7.05, valued at
$105.8k
|
|
12/05/2017 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Gifted 250 shares
@ $0 Gifted 200 shares
@ $0 Gifted 400 shares
@ $0 |
|
06/12/2017 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Granted 13,000 options to buy
@ $10.55, valued at
$137.2k
|
|
06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|